Cutler Group’s Aimmune Therapeutics, Inc. AIMT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-300
| Closed | -$10K | – | 2627 |
|
|
2020
Q3 | $10K | Hold |
300
| – | – | ﹤0.01% | 1320 |
|
|
2020
Q2 | $5K | Buy |
300
+100
| +50% | +$1.67K | ﹤0.01% | 1351 |
|
|
2020
Q1 | $2K | Buy |
+200
| New | +$2K | ﹤0.01% | 1323 |
|
|
2019
Q4 | – | Sell |
-7,400
| Closed | -$154K | – | 2386 |
|
|
2019
Q3 | $154K | Buy |
7,400
+6,100
| +469% | +$127K | 0.01% | 499 |
|
|
2019
Q2 | $27K | Sell |
1,300
-2,000
| -61% | -$41.5K | ﹤0.01% | 1095 |
|
|
2019
Q1 | $73K | Buy |
3,300
+1,300
| +65% | +$28.8K | 0.01% | 724 |
|
|
2018
Q4 | $47K | Sell |
2,000
-5,100
| -72% | -$120K | ﹤0.01% | 850 |
|
|
2018
Q3 | $193K | Buy |
+7,100
| New | +$193K | 0.01% | 567 |
|
|
2018
Q2 | – | Sell |
-3,000
| Closed | -$95K | – | 2495 |
|
|
2018
Q1 | $95K | Buy |
+3,000
| New | +$95K | 0.01% | 753 |
|
|
2017
Q4 | – | Sell |
-7,800
| Closed | -$193K | – | 3091 |
|
|
2017
Q3 | $193K | Buy |
7,800
+6,900
| +767% | +$171K | 0.01% | 768 |
|
|
2017
Q2 | $18K | Buy |
900
+700
| +350% | +$14K | ﹤0.01% | 1917 |
|
|
2017
Q1 | $4K | Sell |
200
-400
| -67% | -$8K | ﹤0.01% | 2486 |
|
|
2016
Q4 | $12K | Sell |
600
-1,500
| -71% | -$30K | ﹤0.01% | 2149 |
|
|
2016
Q3 | $31K | Buy |
+2,100
| New | +$31K | ﹤0.01% | 1656 |
|
|
2016
Q2 | – | Hold |
0
| – | – | – | 3584 |
|
|
2016
Q1 | – | Hold |
0
| – | – | – | 3600 |
|
|
2015
Q4 | – | Hold |
0
| – | – | – | 3427 |
|